Day: July 16, 2021

VANCOUVER, British Columbia, July 15, 2021 (GLOBE NEWSWIRE) — A.I.S. Resources Limited (TSXV: AIS, OTCQB: AISSF) (the “Company” or “AIS”) announces that effective July 9, 2021 the Company’s ISIN changed from “BS0014301076” to “CA0014311058”. Concurrently, the Company’s CUSIP changed from “001430107” to “001431105”. The change was due to a change of jurisdiction. There was no change in the Company’s name, no change in its trading symbol and no consolidation of capital. About A.I.S. Resources Limited A.I.S. Resources Limited is a publicly traded investment issuer listed on the TSX Venture Exchange focused on precious and base metals exploration. AIS’ value add strategy is to acquire prospective exploration projects and enhance their value by better defining the mineral resource with a view to attracting joint venture partners...

GRAND CAYMAN, Cayman Islands, July 15, 2021 (GLOBE NEWSWIRE) — Patria Investments Limited, or “Patria” (PAX: NASDAQ), through its affiliated investment funds, announces the completion of the initial public offering of portfolio company SmartFit. The company priced shares at R$23 and began trading on the Brazilian B3 Stock Exchange on July 14th, 2021 under the ticker SMFT3. The listing raised at least R$2.3 billion in a 100% primary offering, with the potential for upsizing through an over-allotment option. SmartFit is the first publicly listed fitness club operator in Latin America and the 5th largest Brazilian IPO in 2021. Patria’s current stake in SmartFit is held in its fifth private equity fund, as well as related co-investment vehicles. Private Equity Fund V is a 2015 vintage fund with $1.8 billion in commitments and 9 portfolio...

TORONTO, July 15, 2021 (GLOBE NEWSWIRE) — SULLIDEN MINING CAPTIAL INC. (“Sulliden” or the “Company”) (TSX: AAB) has acquired 24,720,943 units of Medivolve Inc. (“Medivolve”) (NEO: MEDV) in a non-brokered private placement financing of MEDV at a price of $0.07 per unit for a total subscription price of $1,730,466.01. Each unit is comprised of one Medivolve common share and one Medivolve common share purchase warrant. Each common share purchase warrant is exercisable for one common share of Medivolve at a price of $0.08 for a period of five years. Prior to the closing of the MEDIVOLVE private placement, Sulliden held 215,000 common shares and 2,040,000 warrants, representing approximately 0.1% of MEDIVOLVE’s issued and outstanding common shares and 1% on a partially diluted basis. Subsequent to the closing of MEDIVOLVE’s private...

TORONTO, July 15, 2021 (GLOBE NEWSWIRE) — ABERDEEN INTERNATIONAL INC. (“Aberdeen” or the “Company”) (TSX: AAB) has acquired 24,101,803 units of Medivolve Inc. (“Medivolve”) (NEO: MEDV) in a non-brokered private placement financing of MEDV at a price of $0.07 per unit for a total subscription price of $1,687,126.21. Each unit is comprised of one Medivolve common share and one Medivolve common share purchase warrant. Each common share purchase warrant is exercisable for one common share of Medivolve at a price of $0.08 for a period of five years. Prior to this transaction, Aberdeen did not own Common Shares of MEDIVOLVE. Subsequent to the closing of MEDIVOLVE’s private placement on July 9, 2021, Aberdeen held 24,101,803 Common Shares and 24,101,803 Warrants, representing 6.2% of MEDIVOLVE’s issued and outstanding Common Shares and...

– EMA commences review of surufatinib for the treatment of advanced neuroendocrine tumors – – Expands potential global reach of surufatinib, in addition to China where it is already launched, and in the U.S. where it is under review for marketing approval – HONG KONG, SHANGHAI, China and FLORHAM PARK, N.J., July 15, 2021 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX: 13) today announces that the European Medicines Agency (“EMA”) has validated and accepted its marketing authorization application (“MAA”) for surufatinib for the treatment of pancreatic and extra-pancreatic (non-pancreatic) neuroendocrine tumors (“NETs”). The EMA’s validation confirms that the submission is sufficiently complete and that it is ready to commence the formal review process. The submission follows scientific advice from...

CHICO, Calif., July 15, 2021 (GLOBE NEWSWIRE) — Northern California National Bank (“NorCal” or the “Bank”) announced today the results of the previously announced cash tender offer by investors seeking to acquire all of the outstanding shares of NorCal (the “Investors”), a planned reverse stock split and closing of its stock transfer records during the pendency of the reverse stock split. The tender offer expired at 5:00, p.m., Pacific Time, on July 9, 2021. As of the expiration of the tender offer, a total of 1,364,390 shares of NorCal common stock, representing approximately 94.1% of the outstanding NorCal shares, were validly tendered into and not validly withdrawn from the tender offer. On July 14, 2021, the tender offer was consummated with the Investors now owning 94.1% of the outstanding shares of all the voting capital...

“Taranaki Sun” Methanol Dual-fueled Methanol Carrier VesselIn 2016, Methanex, WFS and MOL, in conjunction with other key partners, jointly built the first ocean-going dual-fuel vessels, including the Taranaki Sun, capable of running on methanolVANCOUVER, British Columbia and TOKYO, July 15, 2021 (GLOBE NEWSWIRE) — Methanex Corporation (TSX:MX) (NASDAQ:MEOH) (Methanex) and Mitsui O.S.K. Lines, Ltd. (TSE:9104) (MOL) are pleased to announce that the parties have concluded Key Commercial Terms for the purchase and sale of an equity position in, and the establishment of a strategic partnership involving, Methanex’s Waterfront Shipping (WFS) subsidiary. With a fleet of approximately 800 vessels, MOL is one of the world’s largest shipping companies. WFS is a global marine transportation company and operates the world’s...